Company: CSDX
Filing Date: 2025-07-29
Form Type: 10-12G
Source: 0001214659-25-010996
Chunk: 3

Company: CS DIAGNOSTICS CORP.
Filing Date: 2025-07-29
Form: 10-12G
Chunk 3
---
| 3.3         | Amended and Restated Preferred Series B Designation              |
| 3.4         | Amended and Restated Preferred Series C Designation              |
| 10.1        | PatientTrac Limited Securities Purchase Agreement, April 4, 2022 |
| 10.2        | CS Interpharm Asset Purchase Agreement, September 4, 2023        |
| 99.1        | Information Statement                                            |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized.

| Date: July 28, 2025 | CS Diagnostics Corp. |                     |
|:--------------------|:---------------------|:--------------------|
|                     | By:                  | /s/Mohammad EsSayed |
|                     |                      | Mohammad EsSayed    |
|                     |                      | Group CFO, VP       |